1. Metabolic Enzyme/Protease Autophagy
  2. NAMPT Autophagy
  3. GPP78

GPP78  (Synonyms: CAY10618)

目录号: HY-14374 纯度: ≥99.0%
COA 产品使用指南 技术支持

GPP78 (CAY10618) 是一种有效的烟酰胺磷酸核糖转移酶 (Nampt) 抑制剂,对 NAD 消耗的 IC50 为 3 nM。GPP78 通过诱导自噬对神经母细胞瘤细胞 SH-SY5Y 具有毒性,IC50 为 3.8 nM。GPP78 具有抗癌和抗炎作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

GPP78 Chemical Structure

GPP78 Chemical Structure

CAS No. : 1202580-59-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg (11.38 mM * 200 μL in Methanol) ¥1150
In-stock
5 mg (11.38 mM * 1 mL in Methanol) ¥3500
In-stock

* Please select Quantity before adding items.

Customer Review

MCE 顾客使用本产品发表的 1 篇科研文献

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

GPP78 (CAY10618) is a potent Nampt inhibitor with an IC50 of 3.0 nM for nicotinamide adenine dinucleotide (NAD) depletion. GPP78 is cytotoxic to neuroblastoma cell line SH-SY5Y cells with an IC50 of 3.8 nM by inducing autophagy. GPP78 has anti-cancer and anti-inflammatory effects[1][2].

IC50 & Target

Nampt[1];
Autophagy[1]

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
786-0 GI50
7.33 μM
Compound: 8
Growth inhibition of human 786-0 cells by sulforhodamine B assay
Growth inhibition of human 786-0 cells by sulforhodamine B assay
[PMID: 19961183]
A498 GI50
1.59 x 10-5 M
Compound: 8
Growth inhibition of human A498 cells by sulforhodamine B assay
Growth inhibition of human A498 cells by sulforhodamine B assay
[PMID: 19961183]
A549 GI50
2.1 μM
Compound: 8
Growth inhibition of human A549 cells by sulforhodamine B assay
Growth inhibition of human A549 cells by sulforhodamine B assay
[PMID: 19961183]
ACHN GI50
1.87 x 10-5 M
Compound: 8
Growth inhibition of human ACHN cells by sulforhodamine B assay
Growth inhibition of human ACHN cells by sulforhodamine B assay
[PMID: 19961183]
BT-549 GI50
1.7 μM
Compound: 8
Growth inhibition of human BT549 cells by sulforhodamine B assay
Growth inhibition of human BT549 cells by sulforhodamine B assay
[PMID: 19961183]
CAKI-1 GI50
7.76 x 10-1 μM
Compound: 8
Growth inhibition of human Caki1 cells by sulforhodamine B assay
Growth inhibition of human Caki1 cells by sulforhodamine B assay
[PMID: 19961183]
CCRF-CEM GI50
3.28 μM
Compound: 8
Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay
Growth inhibition of human CCRF-CEM cells by sulforhodamine B assay
[PMID: 19961183]
COLO 205 GI50
1.18 μM
Compound: 8
Growth inhibition of human COLO205 cells by sulforhodamine B assay
Growth inhibition of human COLO205 cells by sulforhodamine B assay
[PMID: 19961183]
DU-145 GI50
7.02 x 10-1 μM
Compound: 8
Growth inhibition of human DU145 cells by sulforhodamine B assay
Growth inhibition of human DU145 cells by sulforhodamine B assay
[PMID: 19961183]
EKVX GI50
8.46 μM
Compound: 8
Growth inhibition of human EKVX cells by sulforhodamine B assay
Growth inhibition of human EKVX cells by sulforhodamine B assay
[PMID: 19961183]
HCC 2998 GI50
7 x 10-1 μM
Compound: 8
Growth inhibition of human HCC2998 cells by sulforhodamine B assay
Growth inhibition of human HCC2998 cells by sulforhodamine B assay
[PMID: 19961183]
HCT-116 GI50
4.03 x 10-2 μM
Compound: 8
Growth inhibition of human HCT116 cells by sulforhodamine B assay
Growth inhibition of human HCT116 cells by sulforhodamine B assay
[PMID: 19961183]
HCT-15 GI50
2.57 x 10-1 μM
Compound: 8
Growth inhibition of human HCT15 cells by sulforhodamine B assay
Growth inhibition of human HCT15 cells by sulforhodamine B assay
[PMID: 19961183]
HOP-62 GI50
2.38 x 10-5 M
Compound: 8
Growth inhibition of human HOP62 cells by sulforhodamine B assay
Growth inhibition of human HOP62 cells by sulforhodamine B assay
[PMID: 19961183]
HOP-92 GI50
9.74 x 10-5 M
Compound: 8
Growth inhibition of human HOP92 cells by sulforhodamine B assay
Growth inhibition of human HOP92 cells by sulforhodamine B assay
[PMID: 19961183]
Hs-578T GI50
2.04 x 10-5 M
Compound: 8
Growth inhibition of human Hs 578T cells by sulforhodamine B assay
Growth inhibition of human Hs 578T cells by sulforhodamine B assay
[PMID: 19961183]
HT-29 GI50
4.6 x 10-1 μM
Compound: 8
Growth inhibition of human HT-29 cells by sulforhodamine B assay
Growth inhibition of human HT-29 cells by sulforhodamine B assay
[PMID: 19961183]
IGROV-1 GI50
2.72 x 10-1 μM
Compound: 8
Growth inhibition of human IGROV1 cells by sulforhodamine B assay
Growth inhibition of human IGROV1 cells by sulforhodamine B assay
[PMID: 19961183]
KM12 GI50
1.03 μM
Compound: 8
Growth inhibition of human KM12 cells by sulforhodamine B assay
Growth inhibition of human KM12 cells by sulforhodamine B assay
[PMID: 19961183]
LOX IMVI GI50
1.01 x 10-5 M
Compound: 8
Growth inhibition of human LOXIMVI cells by sulforhodamine B assay
Growth inhibition of human LOXIMVI cells by sulforhodamine B assay
[PMID: 19961183]
M14 GI50
1.66 x 10-1 μM
Compound: 8
Growth inhibition of human M14 cells by sulforhodamine B assay
Growth inhibition of human M14 cells by sulforhodamine B assay
[PMID: 19961183]
Malme-3M GI50
1.22 x 10-5 M
Compound: 8
Growth inhibition of human MALME-3M cells by sulforhodamine B assay
Growth inhibition of human MALME-3M cells by sulforhodamine B assay
[PMID: 19961183]
MCF7 GI50
3.42 μM
Compound: 8
Growth inhibition of human MCF7 cells by sulforhodamine B assay
Growth inhibition of human MCF7 cells by sulforhodamine B assay
[PMID: 19961183]
MDA-MB-231 GI50
2.09 x 10-5 M
Compound: 8
Growth inhibition of human MDA-MB-231 cells by sulforhodamine B assay
Growth inhibition of human MDA-MB-231 cells by sulforhodamine B assay
[PMID: 19961183]
MDA-MB-435 GI50
3.99 x 10-1 μM
Compound: 8
Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay
Growth inhibition of human MDA-MB-435 cells by sulforhodamine B assay
[PMID: 19961183]
MDA-MB-468 GI50
7.34 μM
Compound: 8
Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay
Growth inhibition of human MDA-MB-468 cells by sulforhodamine B assay
[PMID: 19961183]
NCI/ADR-RES GI50
8.14 x 10-2 μM
Compound: 8
Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay
Growth inhibition of human NCI/ADR-RES cells by sulforhodamine B assay
[PMID: 19961183]
NCI-H226 GI50
1.55 x 10-5 M
Compound: 8
Growth inhibition of human NCI-H226 cells by sulforhodamine B assay
Growth inhibition of human NCI-H226 cells by sulforhodamine B assay
[PMID: 19961183]
NCI-H23 GI50
1.51 x 10-5 M
Compound: 8
Growth inhibition of human NCI-H23 cells by sulforhodamine B assay
Growth inhibition of human NCI-H23 cells by sulforhodamine B assay
[PMID: 19961183]
NCI-H322M GI50
2.31 x 10-5 M
Compound: 8
Growth inhibition of human NCI-H322M cells by sulforhodamine B assay
Growth inhibition of human NCI-H322M cells by sulforhodamine B assay
[PMID: 19961183]
NCI-H460 GI50
7.24 x 10-1 μM
Compound: 8
Growth inhibition of human NCI-H460 cells by sulforhodamine B assay
Growth inhibition of human NCI-H460 cells by sulforhodamine B assay
[PMID: 19961183]
NCI-H522 GI50
9.14 x 10-2 μM
Compound: 8
Growth inhibition of human NCI-H522 cells by sulforhodamine B assay
Growth inhibition of human NCI-H522 cells by sulforhodamine B assay
[PMID: 19961183]
OVCAR-3 GI50
5.19 μM
Compound: 8
Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay
Growth inhibition of human OVCAR-3 cells by sulforhodamine B assay
[PMID: 19961183]
OVCAR-4 GI50
3.16 x 10-5 M
Compound: 8
Growth inhibition of human OVCAR4 cells by sulforhodamine B assay
Growth inhibition of human OVCAR4 cells by sulforhodamine B assay
[PMID: 19961183]
OVCAR-5 GI50
2.68 x 10-1 μM
Compound: 8
Growth inhibition of human OVCAR5 cells by sulforhodamine B assay
Growth inhibition of human OVCAR5 cells by sulforhodamine B assay
[PMID: 19961183]
OVCAR-8 GI50
5.74 x 10-2 μM
Compound: 8
Growth inhibition of human OVCAR8 cells by sulforhodamine B assay
Growth inhibition of human OVCAR8 cells by sulforhodamine B assay
[PMID: 19961183]
PC-3 GI50
4.67 x 10-1 μM
Compound: 8
Growth inhibition of human PC3 cells by sulforhodamine B assay
Growth inhibition of human PC3 cells by sulforhodamine B assay
[PMID: 19961183]
RXF 393 GI50
1 x 10-4 M
Compound: 8
Growth inhibition of human RXF393 cells by sulforhodamine B assay
Growth inhibition of human RXF393 cells by sulforhodamine B assay
[PMID: 19961183]
SF-268 GI50
2.47 x 10-5 M
Compound: 8
Growth inhibition of human SF268 cells by sulforhodamine B assay
Growth inhibition of human SF268 cells by sulforhodamine B assay
[PMID: 19961183]
SF-295 GI50
6.55 x 10-1 μM
Compound: 8
Growth inhibition of human SF295 cells by sulforhodamine B assay
Growth inhibition of human SF295 cells by sulforhodamine B assay
[PMID: 19961183]
SF-539 GI50
6.18 x 10-2 μM
Compound: 8
Growth inhibition of human SF539 cells by sulforhodamine B assay
Growth inhibition of human SF539 cells by sulforhodamine B assay
[PMID: 19961183]
SH-SY5Y IC50
3.8 nM
Compound: 8
Cytotoxicity against human SH-SY5Y cells assessed as cell viability after 48 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells assessed as cell viability after 48 hrs by MTT assay
[PMID: 19961183]
SK-MEL-2 GI50
1.28 x 10-5 M
Compound: 8
Growth inhibition of human SK-MEL-2 cells by sulforhodamine B assay
Growth inhibition of human SK-MEL-2 cells by sulforhodamine B assay
[PMID: 19961183]
SK-MEL-28 GI50
1.59 μM
Compound: 8
Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay
Growth inhibition of human SK-MEL-28 cells by sulforhodamine B assay
[PMID: 19961183]
SK-MEL-5 GI50
2.64 x 10-5 M
Compound: 8
Growth inhibition of human SK-MEL-5 cells by sulforhodamine B assay
Growth inhibition of human SK-MEL-5 cells by sulforhodamine B assay
[PMID: 19961183]
SK-OV-3 GI50
2.05 x 10-5 M
Compound: 8
Growth inhibition of human SKOV3 cells by sulforhodamine B assay
Growth inhibition of human SKOV3 cells by sulforhodamine B assay
[PMID: 19961183]
SN12C GI50
4.26 x 10-2 μM
Compound: 8
Growth inhibition of human SN12C cells by sulforhodamine B assay
Growth inhibition of human SN12C cells by sulforhodamine B assay
[PMID: 19961183]
SNB-19 GI50
4.5 x 10-1 μM
Compound: 8
Growth inhibition of human SNB19 cells by sulforhodamine B assay
Growth inhibition of human SNB19 cells by sulforhodamine B assay
[PMID: 19961183]
SNB-75 GI50
2.98 x 10-5 M
Compound: 8
Growth inhibition of human SNB75 cells by sulforhodamine B assay
Growth inhibition of human SNB75 cells by sulforhodamine B assay
[PMID: 19961183]
SW-620 GI50
6.15 x 10-2 μM
Compound: 8
Growth inhibition of human SW620 cells by sulforhodamine B assay
Growth inhibition of human SW620 cells by sulforhodamine B assay
[PMID: 19961183]
T47D GI50
1.23 μM
Compound: 8
Growth inhibition of human T47D cells by sulforhodamine B assay
Growth inhibition of human T47D cells by sulforhodamine B assay
[PMID: 19961183]
TK-10 GI50
1.82 x 10-5 M
Compound: 8
Growth inhibition of human TK10 cells by sulforhodamine B assay
Growth inhibition of human TK10 cells by sulforhodamine B assay
[PMID: 19961183]
U-251 GI50
5.21 x 10-1 μM
Compound: 8
Growth inhibition of human U251 cells by sulforhodamine B assay
Growth inhibition of human U251 cells by sulforhodamine B assay
[PMID: 19961183]
UACC-257 GI50
1.33 x 10-5 M
Compound: 8
Growth inhibition of human UACC257 cells by sulforhodamine B assay
Growth inhibition of human UACC257 cells by sulforhodamine B assay
[PMID: 19961183]
UACC-62 GI50
1.33 x 10-5 M
Compound: 8
Growth inhibition of human UACC62 cells by sulforhodamine B assay
Growth inhibition of human UACC62 cells by sulforhodamine B assay
[PMID: 19961183]
UO-31 GI50
1.69 x 10-5 M
Compound: 8
Growth inhibition of human UO31 cells by sulforhodamine B assay
Growth inhibition of human UO31 cells by sulforhodamine B assay
[PMID: 19961183]
体外研究
(In Vitro)

GPP78 (Compound 8; 10 nM; 24-40 hours; SH-SY5Y cells) treatment with cells, punctate staining of LC3-II and the formation of autophagolysosomes are observable. LC3-II is membrane-bound and is present in autophagosomes[1].
GPP78 (Compound 8) inhibits the growth of most cell lines tested, with nanomolar potency (GI50) in cell lines derived from leukemia, lung, CNS, colon, melanoma, ovarian, renal, and prostate cancers. GPP78 appears truly cytotoxic in melanoma cell lines, while in the others it is mainly cytostatic[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: SH-SY5Y cells
Concentration: 10 nM
Incubation Time: 24 hours, 40 hours
Result: Punctate staining of LC3-II and the formation of autophagolysosomes were observable.
体内研究
(In Vivo)

GPP78 (10 mg/kg; intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days; male adult CD1 mice) treatment reduces the severity of spinal cord trauma in SCI mice[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male adult CD1 mice (25-30 g) with spinal cord injury (SCI)[2]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days
Result: Significantly reduced the demyelination associated with SCI. And significantly ameliorated the functional deficits induced by SCI.
分子量

439.55

Formula

C27H29N5O

CAS 号
性状

液体

颜色

Colorless to light yellow

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Solution, -20°C, 2 years

纯度 & 产品资料

纯度: ≥99.0%

参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
GPP78
目录号:
HY-14374
需求量: